FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
15 letters match. Newest first.
-
Drugs7Tabz Retail, LLC
FDA says 7Tabz Retail sells unapproved 7-OH drug products online with drug-like claims.
High risk -
FoodRoyal Diamond Imports, Inc.
FDA warned Royal Diamond Imports that its Roxy 7-OH kratom tablets are unapproved new drugs and its kratom drink mix contains an unsafe food additive.
High risk -
FoodShaman Botanicals, LLC
FDA warns Shaman Botanicals that its 7-OH chewable tablets are adulterated dietary supplements.
High risk -
FoodRelax Relief Rejuvenate Trading, LLC dba RRR Trading or EDP Kratom
FDA says RRR Trading's EDP 7OH kratom extract shot is an adulterated supplement; its 7-OH ingredient lacks safety evidence.
High risk -
FoodThang Botanicals, Inc. d/b/a 7ΩHMZ, 7-OHMZ, or 7OHMZ
FDA says Thang Botanicals' 7OHMZ kratom shot, tablets, and gummies contain unsafe 7-OH and are adulterated.
High risk -
FoodHydroxie, LLC
FDA warned Hydroxie, LLC that its 7-OH tablets, strips, shots, and drink mix are unapproved drugs and an unsafe food additive.
High risk -
FoodMy Smoke Wholesale
My Smoke Wholesale's 777 Jackpot Alkaloids tablets are adulterated dietary supplements because 7-OH lacks adequate safety information.
High risk -
TobaccoVape Hut, LLC d/b/a Vape Hut Kratom-CBD
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DrugsShot of Joy LLC
FDA warned Shot of Joy LLC that its kratom and kava products are unapproved new drugs marketed for opioid addiction and other conditions.
High risk -
DrugsSunshine Trading Company, Inc. dba Nova Tea and Nova Kratom
FDA warned Nova Kratom that its kratom products are unapproved new drugs marketed to treat opioid addiction and withdrawal.
High risk -
DrugsHerbsens Botanicals
Herbsens Botanicals marketed kratom capsules and powders as unapproved drugs to treat opioid addiction and other conditions.
High risk -
DrugsKlarity Kratom
Klarity Kratom sold kratom products as unapproved drugs claiming they treat opioid addiction, FDA and FTC say.
High risk -
DrugsKratom Exchange
FDA and FTC warned Kratom Exchange that it sells kratom as unapproved new drugs for opioid addiction and other conditions.
High risk -
DrugsOmni Consumer Products LLC d/b/a YoKratom
FDA and FTC warned YoKratom that its kratom products are unapproved new drugs marketed to treat opioid addiction.
High risk -
DrugsUmbrella
FDA warned Umbrella that its supplement and drug products, including Alpha Male Plus with hidden tadalafil, are unapproved and misbranded.
High risk